and the advancement of brepocitinib to Phase 3 trials for non-infectious uveitis, a form of eye inflammation. Roivant ...

Die Investmentfirma H.C. Wainwright bekräftigte am Dienstag ihre positive Einschätzung für die Aktien von Kiora Pharmaceuticals (NASDAQ:KPRX) und bestätigte sowohl die Kaufempfehlung als auch das Kurs ...

Am Dienstag bestätigte H.C. Wainwright seine Kaufempfehlung und das Kursziel von 10,00 US-Dollar für Kiora Pharmaceuticals (NASDAQ:KPRX) nach der Veröffentlichung des Finanzberichts für das dritte Qua ...

Santen Pharmaceutical and Arctic Vision have signed a commercial collaboration agreement for the ARVN001to treat uveitic ...

The three most common types of inflammatory eye disease were keratitis (26 cases, or 33%), uveitis (25 cases, or 32%), and ...

A diagnostic delay of 2 to 6 years may be typical in axSpA, noted Raj Sengupta, MBBS, of the University of Bath in England, ...

Partnership Creates New Opportunities to Address Unmet Needs Related to Posterior Segment Eye Diseases in China - ...

SightMD NJ, a leading multi-specialty ophthalmology platform in New Jersey, welcomes Marez Megalla, MD to its expert team. Dr. Marez Megalla is a board-certified ophthalmologist and fellowship trained ...

The global antimicrobial susceptibility testing market is projected to reach USD 5.68 billion by 2029 from USD 4.45 billion ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Welcome Dr. Marez Megalla, MD to SightMD New Jersey's expert team of ophthalmologists and vitreoretinal surgeons.

Patients with late-onset axial spondyloarthritis (axSpA) are less likely to be positive for human leukocyte antigen B27 (HLA-B27) and have a family history of SpA; they are more likely to present with ...